Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis

J Alzheimers Dis. 2024;99(4):1207-1215. doi: 10.3233/JAD-240119.

Abstract

Higher blood pressure variability (BPV) predisposes to cognitive decline. To investigate underlying mechanisms, we measured 24-h ambulatory BPV, nocturnal dipping and orthostatic hypotension in 518 participants with vascular cognitive impairment, carotid occlusive disease, heart failure, or reference participants. We determined cross-sectional associations between BPV indices and plasma biomarkers of neuronal injury (neurofilament light chain) and Alzheimer's disease (phosphorylated-tau-181 and Aβ42/Aβ40). None of the BPV indices were significantly associated with any of the biomarkers. Hence, in patients with diseases along the heart-brain axis, we found no evidence for an association between BPV and selected markers of neuronal injury or Alzheimer's disease.

Keywords: Alzheimer’s disease; amyloid; biomarkers; blood pressure; dementia; orthostatic hypotension; tau proteins.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / blood
  • Amyloid beta-Peptides* / blood
  • Biomarkers* / blood
  • Blood Pressure* / physiology
  • Brain
  • Cross-Sectional Studies
  • Female
  • Heart Failure / blood
  • Heart Failure / physiopathology
  • Humans
  • Hypotension, Orthostatic / blood
  • Hypotension, Orthostatic / physiopathology
  • Male
  • Middle Aged
  • Neurofilament Proteins / blood
  • Peptide Fragments / blood
  • tau Proteins* / blood

Substances

  • Biomarkers
  • Amyloid beta-Peptides
  • tau Proteins
  • Peptide Fragments
  • Neurofilament Proteins
  • neurofilament protein L
  • amyloid beta-protein (1-42)
  • amyloid beta-protein (1-40)